| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
* Gladstone Institute of Virology and Immunology, University of California, San Francisco, CA 94141;
Center for Infectious Medicine, Department of Medicine, Karolinska Institute, Stockholm, Sweden;
Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY 10461; and
Children’s National Medical Center, Washington, DC 20010
The immunology of vertical HIV transmission differs from that of adult infection in that the immune system of the infant is not fully matured, and the factors that influence the functionality of CD8+ T cell responses against HIV in children remain largely undefined. We have investigated CD8+ T cell responses in 65 pediatric subjects with vertically acquired HIV-1 infection. Vigorous, broad, and Ag dose-driven CD8+ T cell responses against HIV Ags were frequently observed in children who were older than 3 years of age and maintained CD4+ T cell counts >400 cells/µl. In contrast, younger age or a CD4+ T cell count <400 cells/µl was associated with poor CD8+ T cell responses and high HIV loads. Furthermore, subjects with a severely depleted and phenotypically altered CD4+ T cell compartment had circulating Gag-specific CD8+ T cells with impaired IFN-
production. When viral load was not suppressed by antiviral treatment, subjects that fell below the putative age and CD4+ T cell count thresholds had significantly reduced CD8+ T cell responses and significantly higher viral loads. Thus, the data suggest that fully effective HIV-specific CD8+ T cell responses take years to develop despite an abundance of Ag in early life, and responses are further severely impaired, independent of age, in children who have a depleted or skewed CD4+ T cell compartment. The results are discussed in relation to differences between the neonatal and adult immune systems in the ability to respond to HIV infection.
This article has been cited by other articles:
|
|
 |
|
  C. F. Thobakgale, D. Ramduth, S. Reddy, N. Mkhwanazi, C. de Pierres, E. Moodley, W. Mphatswe, N. Blanckenberg, A. Cengimbo, A. Prendergast, et al. Human Immunodeficiency Virus-Specific CD8+ T-Cell Activity Is Detectable from Birth in the Majority of In Utero-Infected Infants J. Virol., December 1, 2007; 81(23): 12775 - 12784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. B. Willberg, S. K. Pillai, E. R. Sharp, M. G. Rosenberg, J. D. Agudelo, J. D. Barbour, and D. F. Nixon Rational Peptide Selection To Detect Human Immunodeficiency Virus Type 1-Specific T-Cell Responses under Resource-Limited Conditions Clin. Vaccine Immunol., June 1, 2007; 14(6): 785 - 788. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. C. Miles, M. van der Sande, D. Jeffries, S. Kaye, J. Ismaili, O. Ojuola, M. Sanneh, E. S. Touray, P. Waight, S. Rowland-Jones, et al. Cytomegalovirus Infection in Gambian Infants Leads to Profound CD8 T-Cell Differentiation J. Virol., June 1, 2007; 81(11): 5766 - 5776. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. L. Lohman, J. A. Slyker, B. A. Richardson, C. Farquhar, J. M. Mabuka, C. Crudder, T. Dong, E. Obimbo, D. Mbori-Ngacha, J. Overbaugh, et al. Longitudinal Assessment of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Gamma Interferon Responses during the First Year of Life in HIV-1-Infected Infants J. Virol., July 1, 2005; 79(13): 8121 - 8130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Chakraborty, A.-S. Morel, J. K. Sutton, V. Appay, R. M. Ripley, T. Dong, T. Rostron, S. Ogola, T. Palakudy, R. Musoke, et al. Correlates of Delayed Disease Progression in HIV-1-Infected Kenyan Children J. Immunol., June 15, 2005; 174(12): 8191 - 8199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Aandahl, M. F. Quigley, W. J. Moretto, M. Moll, V. D. Gonzalez, A. Sonnerborg, S. Lindback, F. M. Hecht, S. G. Deeks, M. G. Rosenberg, et al. Expansion of CD7low and CD7negative CD8 T-cell effector subsets in HIV-1 infection: correlation with antigenic load and reversion by antiretroviral treatment Blood, December 1, 2004; 104(12): 3672 - 3678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. L. Shacklett, C. A. Cox, M. F. Quigley, C. Kreis, N. H. Stollman, M. A. Jacobson, J. Andersson, J. K. Sandberg, and D. F. Nixon Abundant Expression of Granzyme A, but Not Perforin, in Granules of CD8+ T Cells in GALT: Implications for Immune Control of HIV-1 Infection J. Immunol., July 1, 2004; 173(1): 641 - 648. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
